| Bioactivity | Valnoctamide (Valmethamide), a derivative of valproate, suppresses benzodiazepine-refractory status epilepticus. Valnoctamide (Valmethamide) acts directly on GABAA receptors[1]. | |||||||||
| Target | GABAA receptor | |||||||||
| Name | Valnoctamide | |||||||||
| CAS | 4171-13-5 | |||||||||
| Formula | C8H17NO | |||||||||
| Molar Mass | 143.23 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Spampanato J, et al. Valnoctamide enhances phasic inhibition: a potential target mechanism for the treatment of benzodiazepine-refractory status epilepticus. Epilepsia. 2014 Sep;55(9):e94-8. |
Valnoctamide
CAS: 4171-13-5 F: C8H17NO W: 143.23
Valnoctamide (Valmethamide), a derivative of valproate, suppresses benzodiazepine-refractory status epilepticus. Valnoct
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.